In a relatively short time, RFK Jr. has forced America to begin to recognize that the food choices they make have significant ...

The deal was signed with the Energize programme, a renewable energy purchasing vehicle for pharmeceutical companies.

On January 29, 2025, the CAFC issued opinions affirming the preliminary injunctions issued against biosimilars of Regeneron’s EYLEA® ...

Alexion Pharmaceuticals v Amgen (UPC_Coa-405/2024) and Alexion Pharmaceuticals v Samsung Bioepis NL BV (UPC_CoA-402/2024); December 20, 2024.

To help provide relief without the risk of abuse and overdoses, one pharmaceutical company is revealing its new pill designed to not trigger those dangers.

The FDA accepted applications for a golimumab biosimilar, while Samsung Biologics reported record sales, and a Japanese ...

We get it; Not everyone is an Apple person and wants an iPad. For Android devotees, Samsung makes arguably the best Android devices, especially tablets. Samsung tablets range from large and ...

The deal follows a $1.06 billion U.S. contract in July 2024 and a $1.24 billion agreement with an Asia-based pharma a few ...

While most of its current revenue comes from the contract manufacturing business, Samsung Biologics aims to increase its exposure in the contract development organization business, which provides a ...

Samsung Electronics announced it would manufacture its latest Galaxy S25 series smartphones locally at its Noida facility in India. Indian engineers played a significant role in the development of the ...

Samsung Biologics achieved record annual revenue of 4.55 trillion won in 2024, with a 23 percent increase year over year.